Title: Strengthening our Health Security Through Resilient Medical Supply Chains Annual Review Act of 2020
Policy area: Health

Summary:
Strengthening our Health Security Through Resilient Medical Supply Chains Annual Review Act of 2020
This bill requires the Department of Homeland Security (DHS) to report annually on the resiliency of U.S. medical supply chains.
In developing this report, DHS must consult with relevant federal agencies and may consult with other experts. Among other topics, the report must assess the vulnerabilities of the supply chains to global disruptions and the dependence on drugs, devices, or other supplies produced outside of the United States.
In addition, DHS shall make unclassified portions of the report publicly available.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8059 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
                                H. R. 8059

 To direct the Secretary of Homeland Security to submit to Congress a 
  report on the security and resilience of the United States medical 
                 supply chains, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            August 14, 2020

 Mr. Trone (for himself and Mr. Joyce of Pennsylvania) introduced the 
   following bill; which was referred to the Committee on Energy and 
 Commerce, and in addition to the Committees on Homeland Security, and 
  Transportation and Infrastructure, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To direct the Secretary of Homeland Security to submit to Congress a 
  report on the security and resilience of the United States medical 
                 supply chains, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Strengthening our Health Security 
Through Resilient Medical Supply Chains Annual Review Act of 2020''.

SEC. 2. REPORT ON SECURITY AND RESILIENCE OF THE UNITED STATES MEDICAL 
              SUPPLY CHAINS.

    (a) In General.--Not later than one year after the date of the 
enactment of this Act, and annually thereafter, the Secretary of 
Homeland Security shall submit to the Committee on Homeland Security of 
the House of Representatives, and the Committee on Homeland Security 
and Government Affairs of the Senate a report on the security and 
resilience of the United States medical supply chains. Such a report 
shall contain a classified annex. The Secretary shall make publicly 
available (including by publication on the website of the Department of 
Homeland Security) the unclassified portion of the report.
    (b) Contents.--The report submitted under subsection (a) shall--
            (1) review the United States supply chains for medical 
        devices, supplies, and drugs and the vulnerability of such 
        supply chains to a global disruption, such as an instance of 
        bioterrorism, a natural disaster, or a public health emergency;
            (2) assess the dependence of the United States on any 
        medical devices, equipment, supplies, countermeasures, 
        vaccines, and drugs produced or sourced outside the United 
        States; and
            (3) identify the actions the Federal government has taken 
        during the year covered by the report--
                    (A) to promote the security and resilience of the 
                United States medical supply chain;
                    (B) to improve medical supply chain redundancy;
                    (C) to encourage the domestic production of medical 
                devices, equipment, supplies, countermeasures, 
                vaccines, and drugs; and
                    (D) to develop contingency plans for potential 
                global disruptions; and
            (4) provide recommendations to agencies of the Federal 
        Government, States, local, tribal, and territorial governments, 
        and the private sector on ways to strengthen the security and 
        resilience of the United States medical supply chain.
    (c) Consultation.--In preparing the report under subsection (a), 
the Secretary of Homeland Security--
            (1) shall consult with the heads of other relevant Federal 
        agencies; and
            (2) may consult with public health experts, health security 
        experts, supply chain experts, and other individuals with 
        relevant experience.
                                 <all>